Cahn Medical Ventures invests for the long term in early-stage medical
technology companies, filling the significant gap that exists between angel
investing and institutional venture capital investing rounds.
Cylex achieves near tripling of Medicare reimbursement READ MORE
TyRx doubles sales in 2010 and raises $20 million in new capital READ MORE
